Abstract 3147A: The use of the sTRA glycan for predicting responses to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma Article

Staal, Ben, Liu, Ying, Hsueh, Peter et al. (2019). Abstract 3147A: The use of the sTRA glycan for predicting responses to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma . CANCER RESEARCH, 79(13_Supplement), 3147a-3147a. 10.1158/1538-7445.am2019-3147a

cited authors

  • Staal, Ben; Liu, Ying; Hsueh, Peter; Aldakkak, Mohammed; Zeh, Herbert; Evans, Douglas; Brand, Randall E; Tsai, Susan; Haab, Brian B

authors

publication date

  • July 1, 2019

published in

keywords

  • 3 Good Health and Well Being
  • 32 Biomedical and Clinical Sciences
  • 3202 Clinical Sciences
  • Cancer
  • Clinical Research
  • Digestive Diseases
  • Orphan Drug
  • Pancreatic Cancer
  • Precision Medicine
  • Prevention
  • Rare Diseases

Digital Object Identifier (DOI)

publisher

  • American Association for Cancer Research (AACR)

start page

  • 3147a

end page

  • 3147a

volume

  • 79

issue

  • 13_Supplement